Author: Fiona Craig
-

Dollar Holds Firm Near Three-Month Peak as Traders Scale Back Rate Cut Bets; Sterling Weakens on U.K. Political Strain
The U.S. dollar remained near a three-month high on Tuesday, supported by fading expectations for additional Federal Reserve rate cuts, while the British pound slipped as political pressures mounted on U.K. finance minister Rachel Reeves. At 04:35 ET (09:35 GMT), the U.S. Dollar Index — which tracks the greenback against a basket of six major…
-

Dow Jones, S&P, Nasdaq, Wall Street, U.S. Futures Slip as Tech Stocks Weigh; Palantir Sinks, AMD Earnings Ahead
U.S. stock futures moved lower early Tuesday, as investors weighed new comments from Federal Reserve officials and a flood of corporate earnings while locking in profits after a volatile start to November. Futures Edge Down By 02:58 ET, Dow futures were down 0.7% (313 points), S&P 500 futures dropped 0.9% (61 points), and Nasdaq 100…
-

Starbucks to Sell Majority Stake in Its China Operations to Boyu Capital
Starbucks (NASDAQ:SBUX) has agreed to sell a 60% stake in its China retail business to Boyu Capital, in a transaction that values the coffee giant’s Chinese operations at over $13 billion. Under the agreement announced Monday, Boyu Capital will take control of the majority share in Starbucks’ retail network in China, while Starbucks will retain…
-

BP Surpasses Expectations with $2.21 Billion Quarterly Profit, Keeps Buybacks Unchanged
BP plc (NYSE:BP) posted an underlying replacement cost (RC) profit of $2.21 billion for the third quarter, coming in slightly ahead of analyst estimates of $2.02 billion, though just below the $2.27 billion reported a year earlier. The company kept its quarterly share buyback program steady at $750 million and reaffirmed plans to complete roughly…
-

U.S. rare earth stocks dip as China plans to ease export restrictions
Shares of U.S. rare earth producers slipped slightly in premarket trading on Monday after reports that China plans to lift some of its additional export restrictions on critical minerals, following diplomatic progress between Washington and Beijing. Critical Metals (NASDAQ:CRML), Energy Fuels (AMEX:UUUU), United States Antimony Corporation (AMEX:UAMY), and NioCorp Developments (NASDAQ:NB) all traded lower ahead…
-

Memory Chip Stocks Rally as Samsung Postpones DDR5 Contract Pricing Amid Sharp Price Surge
Shares of memory chipmakers surged in premarket trading Monday following reports that Samsung Electronics has postponed setting contract prices for its DDR5 memory chips after a sharp rise in spot market prices. Micron Technology (NASDAQ:MU) climbed 4.1%, while SanDisk jumped over 6.1%, leading gains across the semiconductor sector. Other storage names followed suit, with Western…
-

BofA: Gold’s Decline Tied to CTA Selling Pressure
The recent slide in gold prices has been partly attributed to selling by trend-following funds, according to Bank of America (BofA). Analysts noted that commodity trading advisors (CTAs) “continued to unwind gold longs as the yellow metal declined for the second straight week.” “Our more risk-averse models have already stopped out of their gold longs…
-

Microsoft Gains U.S. Approval to Export Nvidia AI Chips to the UAE — FT
Microsoft (NASDAQ:MSFT) has received authorization from the U.S. government to export advanced Nvidia (NASDAQ:NVDA) AI chips to the United Arab Emirates, marking a key step in the company’s expansion across the Middle East, according to the Financial Times. Brad Smith, Microsoft’s president, confirmed that in September, the company became “the first company to receive a…
-

Bruker Shares Dip 3% After Q3 Beat but Weaker Full-Year Outlook
Bruker Corporation (NASDAQ:BRKR) reported third-quarter 2025 earnings that topped expectations, but its shares fell 3.2% in premarket trading after the company issued a full-year forecast that disappointed investors. The scientific instruments manufacturer posted adjusted earnings of $0.45 per share, surpassing the analyst consensus of $0.33. Revenue came in at $860.5 million, ahead of expectations of…
-

Benitec Biopharma Shares Surge 20% After FDA Grants Fast Track Status for OPMD Gene Therapy
Benitec Biopharma Inc. (NASDAQ:BNTC) shares soared 20% on Monday after the biotech company announced positive interim results from its ongoing Phase 1b/2a clinical trial of BB-301 and confirmed that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the therapy. The clinical-stage gene therapy company reported that all six patients in…